Clinically accessible cell signaling: Second messengers in sepsis and trauma

Journal of Surgical Research

Volumn 60, Issue 1, 1996, Pages 270-277

  Rehring, Thomas F ^a,b   Brew, Elizabeth C ^b   Friese, Randall S ^b   Banerjee, Anirban ^b   Harken, Alden H ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; ACETYLSALICYLIC ACID; ADRENALIN; AMRINONE; ARACHIDONIC ACID; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; CELL SURFACE RECEPTOR; CHELERYTHRINE; CORTICOSTEROID; CYCLIC AMP; CYCLIC GMP; DANTROLENE; DIACYLGLYCEROL; DILTIAZEM; DOBUTAMINE; DOPAMINE; GLYCERYL TRINITRATE; INOSITOL TRISPHOSPHATE; ION CHANNEL; NIFEDIPINE; NITROPRUSSIDE SODIUM; PROPRANOLOL; RANITIDINE; STAUROSPORINE; VERAPAMIL;

ARACHIDONIC ACID METABOLISM; CELL MEMBRANE; PRIORITY JOURNAL; REVIEW; SECOND MESSENGER; SEPTIC SHOCK; SIGNAL TRANSDUCTION; TRAUMATIC SHOCK;

EID: 0030056988     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.0042     Document Type: Review

References (37)

1. Banerjee, A., Locke-Winter, C., Rogers, K. B., Mitchell, M. B., Brew, E. C., Cairns, C. B., Bensard, D. D., and Harken, A. H. Preconditioning against myocardial dysfunction after ischemia and reperfusion by an alpha-1 adrenergic mechanism. Circ. Res. 73(4): 656, 1993.
2. Mitchell, M. B., Winter, C. B., Banerjee, A., and Harken, A. H. The relationship between ischemia-reperfusion injury, myocardial "stunning" and cardiac preconditioning. Surg. Gynecol. Obstet. 177: 97, 1993.
3. Brown, J. M., Grosso, M. A., Terada, L. S., Whitman, G. J. R., Banerjee, A., White, C. W., Harken, A. H., and Repine, J. E. Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat hearts. Proc. Natl. Acad. Sci. USA 86: 2516, 1989.
4. Brown, J. M., Anderson, B. O., Shanley, P. F., White, C. W., Grosso, M. A., Banerjee, A., Repine, J. E., Whitman, G., J. R., Bensard, D. D., and Harken, A. H. Neutrophils contribute to TNF induced myocardial tolerance to ischemia. J. Mol. Cell. Cardiol. 24: 485, 1992.
5. Nelson, D. W., Brown, J. M., Banerjee, A., Bensard, D. D., Rogers, K. B., Locke-Winter, C. R., Anderson, B. O., and Harken, A. H. Pretreatment with a nontoxic derivative of endotoxin (MPL) induces functional protection against cardiac ischemia-reperfusion injury. Surgery 110: 365, 1991.
6. Barnard, E. A. Receptor classes and the transmitter-gated ion channels. Trends Biochem. Sci. 17(1): 368, 1992.
7. Birnbaumer, L., Abramowitz, J., and Brown, A. M. Receptor-effector coupling by G proteins. Biochim. Biophys. Acta 1031: 163, 1990.
8. Hepler, J. R., and Gilman, A. G. G proteins. Trends Biochem. Sci. 17(1): 383, 1992.
9. Birnbaumer, L., and Brown, A. M. G proteins and the mechanism of action of hormones, neurotransmitters, and autocrine and paracrine regulatory factors. Am. Rev. Respir. Dis. 141: S106, 1990.
10. Robison, G. A., Butcher, R. W., and Sutherland, E. W. Cyclic AMP and hormone action. In G. A. Robison, R. W. Butcher, and E. W. Sutherland (Eds.), Cyclic AMP. New York: Academic Press, 1971. Pp. 17-47.
11. Scott, J. D. Cyclic nucleotide-dependent protein kinases. Pharmacol. Ther. 50: 123, 1991.
12. McIntyre, R. C., Jr., Harken, A. H., and Fullerton, D. A. Mechanisms of pulmonary vascular control in acute lung injury. Surgery 115(3): 273, 1994.
13. Goy, M. F. cGMP: The wayward child of the cyclic nucleotide family. Trends Neurosci. 14(7): 293, 1991.
14. Hofmann, F., Dostmann, W., Keilbach, A., Landgraf, W., and Ruth, P. Structure and physiologic role of cGMP-dependent protein kinase. Biochim. Biophys. Acta 1135: 51, 1992.
15. Murad, F. Cyclic guanosine monophosphate as a mediator of vasodilation. J. Clin. Invest. 78(July): 1, 1986.
16. Streb, H., Irvine, R. F., Berridge, M. J., and Schulz, I. Release of calcium from a nonmitochondrial intrcellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate. Nature 306, 67, 1983.
17. Nishizuka, Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258(October 23): 607, 1992.
18. Bradshaw, D., Hill, C. H., Nixon, J. S., and Wilkinson, S. E. Therapeutic potential of protein kinase C inhibitors. Agents Actions 38(1-2): 135, 1993.
19. Lew, P. D. Receptors and intracellular signaling in human neutrophils. Am. Rev. Respir. Dis. 141: S127, 1990.
20. Premack, B. A., and Gardner, P. Signal transduction by T-cell receptors: Mobilization of Ca and regulation of Ca-dependent effector molecules. Am. J. Physiol. 263(6, part 1): C1119, 1992.
21. Berridge, M. J. Inositol trisphosphate and calcium signalling. Nature 361(6410): 315, 1993.
22. Taylor, C. B., and Marshall, I. C. B. Calcium and inositol 1,4,5-trisphosphate receptors: A complex relationship. Trends Biochem. Sci. 17(1): 403, 1992.
23. Song, S.-K., Karl, I. E., Ackerman, J. J. H., and Hotchkiss, R. S. Increased intracellular Ca2+: A critical link in the pathophysiology of sepsis? Proc. Natl. Acad. Sci. USA 90(May): 3933, 1993.
24. McPhail, L. C., Clayton, C. C., and Snyderman, R. A potential second messenger role for unsaturated fatty acid: Activation of calcium-dependent protein kinase. Science 224: 622, 1984.
25. Dennis, E. A., Rhee, S. G., Billah, M. M., and Hannun, Y. A. Role of phospholipases in generating lipid second messengers in signal transduction. FASEB J. 5(April): 2068, 1991.
26. Naor, Z. Is arachidonic acid a second messenger in signal transduction. Mol. Cell. Endocrinol. 80: C181, 1991.
27. Baird, N. R., and Morrison, A. R. Amplification of the arachidonic acid cascade: Implications for pharmacologic intervention. Am. J. Kidney Dis. 21(5 May): 557, 1993.
28. Sumida, C., Graber, R., and Nunez, E. Role of fatty acids in signal transduction: Modulators and messengers. Prostaglandins Leukotrienes Essent. Fatty Acids 48: 117, 1993.
29. Chow, S. C., and Jondal, M. Polyunsaturated free fatty acids stimulate an increase in cytosolic calcium by mobilizing the inositol 1,4,5-trisphosphate-sensitive calcium pool in T cells through a mechanism independent of phosphoinositide turnover. J. Biol. Chem. 265(2): 902, 1990.
30. Sigal, E. The molecular biology of mammalian arachidonic acid metabolism. Am. J. Physiol. 260: L13, 1991.
31. Vadas, P., and Pruzanski, W. Induction of group II phospholipase A2 expression and pathogenesis of the sepsis syndrome. Circ. Shock 39(2): 160, 1993.
32. Koike, K., Moore, E. E., Moore, F. A., Kim, F. J., Carl, V., and Banerjee, A. Gut phospholipase A2 mediates PMN priming and lung injury after mesnteric ischemia/reperfusion. Am. J. Physiol. 268(3, part 1): 9397, 1995.
33. Vane, J. R., Anggard, E. E., and Botting, R. M. Regulatory functions of the vascular endothelium. N. Engl. J. Med. 323(1): 27, 1990.
34. Parrillo, J. E. Pathogenic mechanisms of septic shock. N. Engl. J. Med. 328(20): 1471, 1993.
35. Bracken, M. B., Shepard, M. J., Collins, W. F., Holford, T. R., Young, W., Baskin, D. S., Eisenberg, H. M., Flamm, E., Leo-Summers, L., Maroon, J., Marshall, L. F., Perot, P. L., Piepmeier, J., Sonntag, V. K. H., Wagner, F. C., Wilberger, J. E., and Winn, H. R. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury. N. Engl. J. Med. 322(20): 1405, 1990.
36. Karin, M. Signal transduction from cell surface to nucleus in development and disease. FASEB J. 6: 2581, 1992.
37. Karin, M., and Smeal, T. Control of transcription factors by signal transduction pathways: The beginning of the end. Trends Biochem. Sci. 17(1): 418, 1992.